Stay updated on BMN 110 Phase 3B in Australian Patients Clinical Trial
Sign up to get notified when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.

Latest updates to the BMN 110 Phase 3B in Australian Patients Clinical Trial page
- Check6 days agoChange DetectedThe page continues to show a 403 Forbidden error, while the footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check13 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now renders a 403 Forbidden error, replacing the study record content. A Home link appears and the detailed study information is no longer accessible.SummaryDifference17%

- Check55 days agoChange DetectedThe page's Revision tag was updated from v3.6.5 to v3.6.6. This update represents an internal version change and does not alter the study details presented on the page.SummaryDifference0.1%

- Check69 days agoChange DetectedNew MeSH terms and related indexing metadata were added to the study record, including terms such as GALNS protein, enzymes and coenzymes, sulfatases, and various disease/categories. This update expands the tagging and searchability of the record within the indexing taxonomy.SummaryDifference45%

- Check76 days agoChange DetectedThe page shows a revision update from v3.6.4 to v3.6.5, indicating a small publish/patch. No substantive study content appears to be altered by this change.SummaryDifference0.1%

Stay in the know with updates to BMN 110 Phase 3B in Australian Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.